Importantly, this study demonstrates that phenocopying SRC and BCL2L1 LOF by pharmacologic inhibition can sensitize TRAIL-resistant breast cancer cell lines to TRAIL-induced apoptosis. This evidence concerns the gene BCL2L1 and breast carcinoma.